News

Crescent Biopharma Completes Closing Of Merger With Glycomimetics And Previously Announced Private Placement Of $200 Million
Advancing Lead Program, CR-001, a PD-1 x VEGF Bispecific Antibody, and Developing Pipeline of Novel ADCs as Single Agents and in Combination with CR- ...
MarketWatch5d
PagerDuty Inc.
PD Finanicals Stock Screener Earnings Calendar Sectors NYSE Search Ticker | PD U.S.: NYSE PagerDuty Inc. + Watchlist Alert PD US After Hours Last Updated: Jun 13, 2025 7:50 p.m. EDT Delayed quote ...